Constitutive production of a murine retrovirus in the human B- lymphoblastoid cell line, DG-75

Virology

Volumn 250, Issue 1, 1998, Pages 135-139

  Raisch, Kevin P ^a   Kushnaryov, Vladimir M ^a   Grossberg, Sidney E ^a   Cashdollar, L William ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

EBV negative B cells; Lymphoblastoid; Murine retrovirus variant

Indexed keywords

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; RETROVIRUS; VIRUS MORPHOGENESIS; VIRUS TRANSMISSION;

HUMAN HERPESVIRUS 4; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032505539     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9363     Document Type: Article

References (24)

1. Ben-Bassat H., Goldblum N., Mitrani S., Goldblum T., Yoffey J. M., Cohen M. M., Bentwich Z., Ramot B., Klein E., Klein G. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt-like" malignant lymphoma (line D.G.-75). Int. J. Cancer. 19:1977;27-33.
2. Chakrabarti R., Hofman F. M., Pandey R., Mathes L. E., Roy-Burman P. Recombination between feline exogenous and endogenous retroviral sequences generates tropsim for cerebral endothelial cells. Am. J. Pathol. 144:1994;348-358.
3. Cuomo L., Trivedi P., Wang F., Winberg G., Klein G., Masucci M. G. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Eur. J. Immunol. 20:1990;2293-2299.
4. Fåhraeus R., Jansson A., Ricksten A., Sjöblom A., Rymo L. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA. 87:1990;7390-7394.
5. Fåhraeus R., Jansson A., Sjöblom A., Nilsson T., Klein G., Rymo L. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. Virology. 195:1993;71-80.
6. Fåhraeus R., Palmqvist L., Nerdstedt A., Farzad S., Rymo L., Laín S. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity. EMBO J. 13:1994;6041-6051.
7. Finke J., Fritzen R., Ternes P., Trivedi P., Bross K. J., Lange W., Mertelsmann R., Dölken G. Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood. 80:1992;459-469.
8. Floettmann J. E., Ward K., Rickinson A. B., Rowe M. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology. 223:1996;29-40.
9. Frank H. Oncovirinae: Type C oncovirus. Animal Virus Structure. 1987;Elsevier, Newark. p. 273-287.
10. Gerwin B. I., Todaro G. J., Zeve V., Scolnick E. M., Aaronson S. A. Separation of RNA-dependent DNA polymerase activity from the murine leukaemia virion. Nature. 228:1970;435-438.
11. Grossberg S. E., Kushnaryov V. M., Cashdollar L. W., Raisch K. P., Miller G., Sun H.-Y. A human B-lymphoblastoid cell line constitutively producing Epstein-Barr herpesvirus and JHK retrovirus. Res. Virol. 148:1997;191-206.
12. Kotler M., Balabanova H., Ben-Moyal Z., Friedman A., Becker Y. Properties of the oncornavirus particles isolated from P3HR-1 and Raji human lymphoblastoid cell lines. Israel J. Med. Sci. 13:1977;740-746.
13. Levy J. A. Xenotropic viruses: Murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science. 182:1973;11510-11153.
14. Murphy F. A., Kingsbury D. W. Virus taxonomy. Fields B. N., Knipe D. M. Virology. 1990;9-35 Raven Press, New York.
15. Oda T., Ikeda S., Watanabe S., Hatsushika M., Akiyama K., Mitsunobu F. Molecular cloning, complete nucleotide sequence, and gene structure of the provirus genome of a retrovirus produced in a human lymphoblastoid cell line. Virology. 167:1988;468-476.
16. Pandey R., Ghosh A. K., Kumar D. V., Bachman B. A., Shibata D., Roy-Burman P. Recombination between feline leukemia virus subgroup B or C and endogenousenvin vitro. J. Virol. 65:1991;6495-6508.
17. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection an isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
18. Popovič M., Kalyanaraman V. S., Reitz M. S., Sarngdaharan M. G. Identification of the RPMI 8226 retrovirus and its dissemination as a significant contaminant of some widely used human and marmoset cell lines. Int. J. Cancer. 30:1982;93-99.
19. Pyra H., Böni J., Schüpbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. USA. 91:1994;1544-1548.
20. Silins S. L., Sculley T. B. Burkitts lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer. 60:1995;65-72.
21. Sjöblom A., Weiwen Y., Palmqvist L., Jansson A., Rymo L. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter. J. Virol. 72:1998;1365-1376.
22. Sun R., Grogan E., Shedd D., Bykovsky A. F., Kushnaryov V. M., Grossberg S. E., Miller G. Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells. Virology. 209:1995;374-383.
23. Todaro G. J., Arnstein P., Parks W. P., Lennette E. H., Huebner R. J. A type-C virus in human rhabdomyosarcoma cells after inoculation into Swiss mice treated with antithymocyte serum. Proc. Natl. Acad. Sci. USA. 70:1973;859-862.
24. Welinder C., Larsson N.-G., Szigeti R., Ehlin-Henriksson B., Henle G., Henle W., Klein G., Richsten A., Rymo L., Sultizeanu D. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins. Int. J. Cancer. 40:1987;389-395.